- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06625645
Comparative Evaluation of Antimicrobial Efficacy, Clinical and Radiographic Success of Calcium Hydroxide, Chlorhexidine, and Modified Triple Antibiotic Paste in Different Combination Forms As Intracanal Medicaments Against Enterococcus Faecalis in Primary Teeth
Comparative Evaluation of Antimicrobial Efficacy, Clinical and Radiographic Success of Calcium Hydroxide, Chlorhexidine, and Modified Triple Antibiotic Paste in Different Combination Forms As Intracanal Medicaments Against Enterococcus Faecalis in Primary Teeth: a Randomized Clinical Trial
Study Overview
Status
Intervention / Treatment
- Combination product: calcium hydroxide mixed with saline as intracanal medication
- Combination product: Calcium Hydroxide mixed with chlorohexidine Intracanal medication
- Combination product: Modified triple antibiotic paste (TAP) mixed with chlorehexidine
- Combination product: Modified Triple Antibiotic Paste mixed with saline
Detailed Description
- Full medical and dental history will be obtained from the parents of the patients participating in this study.
- A thorough clinical and radiographic examination of the tooth to be treated will be done.
- The tooth will be anaesthetized using the inferior alveolar nerve block technique for lower molars and infiltration for upper molars
- Before isolation, antisepsis of the oral cavity will be performed by rinsing for 1 min with 10 mL chlorhexidine gluconate mouth-wash 0.2 %.
- The tooth will be properly isolated using rubber dam.
- Access cavity will be performed using a round bur.
- The root canals will be irrigated with 1 ml sterile saline solution.
- Patency of the root canal will be obtained using stainless steel hand k- files size #15
- Working length will be determined using apex locator
- The first microbial samples (S1) will be collected to assess bacterial count of the root canals using 1 sterile paper point size 20, which will be inserted into the widest root canal for 1 min with pumping movements (McGurkin-Smith et al., 2005)
- It will be placed inside sterile tubes containing a reduced transport medium of thioglycolate.
- The canals will be thoroughly irrigated using 3ml syringe of 1.25% Sodium hypochlorite. A side-vented needle will be used to control the possibility of irrigant apical extrusion.
- Mechanical preparation will be performed with rotary system for all the cases.
- Irrigation with saline solution will be used to neutralize all the previously used solutions.
- Then, a second microbial samples (S2) representing the antibacterial effect of the mechanical preparation will be obtained with the same procedure as the first sample (S1).
- According to the randomization sequence, patients will be assigned to one of 4 groups:
1- A mix of modified triple Antibiotic Paste (M-TAP) and normal saline (experimental).
2- A mix of Ca(OH)2 and 2% CHX gluconate solution(experimental). 3- A mix of M-TAP and 2% CHX gluconate solution(experimental). 4- A mix of Ca(OH)2 and normal saline (control) 17) The canals will be dried and filled with intracanal medication plugged into the canal by using a plugger.
18) At the end of the first visit a piece of sterile cotton will be placed in the pulp chamber.
19) All teeth will be dressed with intermediate restorative material (IRM) as a temporary filling, in order to ensure proper sealing with no leakage of any oral fluids inside the root canal, which might disturb the action of the intracanal medication.
20) After 7 days, the temporary restoration will be removed. 21) Disinfection of the operative field will take place as performed previously using the same protocol.
22) Irrigation of the root canals with 2 mL of saline to flush out the medicaments and the third bacteriological sample (S3) will be taken out.
23) Later, canals will be filled with Metapex (Metabiomed, Korea), followed by the placement of stainless-steel crowns (3M ESPE).
24) The samples will be placed in sterile vials with thioglycolate (transport medium). The vials will be sealed tightly to avoid contamination and labeled. The labeled vials will be kept in a freezer and will be sent to the laboratory within 1 hour of collection, and samples will be assessed for total E. faecalis count (Qamar et al., 2023).
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Mahy kamar Mahy A.Raouf Kamar, Assistant Lecturer
- Phone Number: 01550831173
- Email: Mahy_kamar@dentistry.cu.edu.eg
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
• Primary molars necessitating pulpectomy diagnosed with deep dental caries with pulp necrosis, apical periodontitis and periapical pathosis or both.
- Non-Vital pulps.
- Negative response to hot or cold pulp tester (ethyl chloride spray ).
- Decayed tooth with spontaneous unprovoked long dull aching pain showing signs of necrosis of the pulp
Exclusion Criteria:
- Medically compromised and uncooperative children
- Tooth indicated for extraction
- Mobile teeth (Miller's Grade 2 or more)
- teeth with more than two-thirds of root resorption
- previous endodontic treatment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Calcium Hydroxide mixed with saline as control intracanal medication
using calcium hydroxide with saline as control intracanal medication for necrotic primary molars
|
calcium hydroxide mixed with saline as intracanal medication for necrotic primary molars
|
|
Experimental: different types and combinations of intracanal medications for necrotic primary molars
|
calcium hydroxide powder mixed with CHX 2% solution as intracanal medication
M-TAP with CHX 2%
M-TAP mixed with saline
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Enterococcus faecalis bacterial reduction
Time Frame: 3 times, one after the access and gaining patency, second one after chemomechanical preparation and the third one after 7 days from intracanal medication insertion in the canal
|
Samples from canal using paper point size 20 with pumping action from the widest canal three times one after the access and gaining patency, second one after chemomechanical preparation and the third one after 7 days from intracanal medication insertion in the canal, then the samples will be placed in sterile vials with thioglycolate (transport medium).
The vials will be sealed tightly to avoid contamination and labeled.
The labeled vials will be kept in a freezer and will be sent to the laboratory within 1 hour of collection, and samples will be assessed for total E. faecalis count.
|
3 times, one after the access and gaining patency, second one after chemomechanical preparation and the third one after 7 days from intracanal medication insertion in the canal
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Clinical success
Time Frame: 3,6 and 12 months
|
measuring pain through presence or absence of pain Visual inspection of any changes (Redness or swelling of vestibular area (presence or absence of any change) Tenderness upon percussion ( positive or negative response) Tenderness upon touching of the vestibulum ( positive or negative response)
|
3,6 and 12 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Radiographic success
Time Frame: 6 and 12 months
|
Digital periapical radiographs for assessing the integrity of the pulp and surrounding structures. Periodontal ligament (PDL) widening, loss of lamina dura, internal or external root resorption, and radiolucency of furcation or periapical pathosis) will be considered as a failure with dichotomous response (yes/no) |
6 and 12 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pathologic Processes
- Stomatognathic Diseases
- Periodontal Diseases
- Mouth Diseases
- Jaw Diseases
- Periapical Diseases
- Periodontitis
- Necrosis
- Periapical Periodontitis
- Physiological Effects of Drugs
- Anti-Infective Agents
- Bone Density Conservation Agents
- Calcium-Regulating Hormones and Agents
- Antitubercular Agents
- Calcium
- Anti-Bacterial Agents
- Antibiotics, Antitubercular
- Calcium, Dietary
Other Study ID Numbers
- 14422023573623
- main investigator (Registry Identifier: Mahy Abdel Raouf)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Apical Periodontitis
-
RANA AHMADNot yet recruitingSymptomatic Apical Periodontitis | Irreversible Pulpitis With Apical Periodontitis
-
Marmara UniversityMarmara University Scientific Research Projects UnitCompletedChronic Apical PeriodontitisTurkey (Türkiye)
-
Mustafa Kemal UniversityActive, not recruitingChronic Apical PeriodontitisTurkey (Türkiye)
-
The Dental Hospital of Zhejiang University School...RecruitingChronic Apical PeriodontitisChina
-
Ataturk UniversityActive, not recruiting
-
Fatima Memorial HospitalRecruitingAsymptomatic Apical PeriodontitisPakistan
-
Suez Canal UniversityUniversity of LeedsActive, not recruitingAsymptomatic Apical PeriodontitisEgypt
-
Aga Khan UniversityCompletedChronic Apical PeriodontitisPakistan
-
bengi gülgüRecruitingOxidative Stress | Chronic Apical PeriodontitisTurkey
-
Nanfang Hospital, Southern Medical UniversityRecruitingChronic Apical PeriodontitisChina
Clinical Trials on calcium hydroxide mixed with saline as intracanal medication
-
Ankara UniversityRecruitingPostoperative Pain | Root Canal Retreatment | Calcium Hydroxide | Medicaments Substances in Therapeutic UseTurkey (Türkiye)
-
Celalettin TopbaşCompletedPeriapical Periodontitis, Chronic NonsuppurativeTurkey (Türkiye)
-
Hadeer Maher Mostafa MohamedRecruitingEndodontically Retard Teeth | Periapical RadiolucencyEgypt
-
Al-Azhar UniversityRecruitingPrevious Endodontic Treatment Failure and Radiographically Confirmed Periapical RadiolucencyEgypt
-
Cairo UniversityNot yet recruitingBiomarkers | Apical Periodontitis | Calcium Hydroxide | Intracanal Dressing | Inflammatory Mediators
-
Minia UniversityNot yet recruitingPostoperative Pain | Diabete Type 2 | Flare up | Flare Up, Symptom
-
Future University in EgyptActive, not recruiting
-
Suez Canal UniversityUniversity of LeedsActive, not recruitingAsymptomatic Apical PeriodontitisEgypt
-
Mansoura UniversityRecruiting
-
Cairo UniversityCompleted